These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 396351)

  • 21. The detrimental effect of early rejection on long-term renal allograft outcome.
    Sumrani N; Delaney V; Daskalakis P; Hong JH; Cacciarelli TV; Sommer BG
    Transplant Proc; 1992 Oct; 24(5):1750-2. PubMed ID: 1412824
    [No Abstract]   [Full Text] [Related]  

  • 22. Pseudorejection and true rejection after kidney transplantation: classification and clinical significance.
    Khater N; Khauli R
    Urol Int; 2013; 90(4):373-80. PubMed ID: 23095211
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serologic diagnosis of acute human renal allograft rejection.
    McDonald JC; Lindsey ES; Hornung MO; Garbus SB; Cocke TB; Gonzalez FM
    Proc Clin Dial Transplant Forum; 1971; 1():80-2. PubMed ID: 4951045
    [No Abstract]   [Full Text] [Related]  

  • 24. Cell proliferation within graft and in blood during renal allograft rejection.
    Häyry P; Pasternack A; Virolainen M
    Transplant Proc; 1972 Jun; 4(2):195-8. PubMed ID: 4556064
    [No Abstract]   [Full Text] [Related]  

  • 25. Safety and tolerability of Neoral vs Sandimmune: 1-year data in primary renal allograft recipients. Neoral Study Group.
    Barone G; Bunke CM; Choc MG; Hricik DE; Jin JH; Klein JB; Marsh CL; Min DI; Pescovitz MD; Pollak R; Pruett TL; Stinson JB; Thompson JS; Vasquez E; Waid T; Wombolt DG; Wong RL
    Transplant Proc; 1996 Aug; 28(4):2183-6. PubMed ID: 8769194
    [No Abstract]   [Full Text] [Related]  

  • 26. Single center experience with renal allograft sharing.
    Cacciarelli T; Sumrani N; Delaney V; DiBenedetto A; Hong JH; Sommer BG
    Transplant Proc; 1991 Oct; 23(5):2672-3. PubMed ID: 1926528
    [No Abstract]   [Full Text] [Related]  

  • 27. Conversion to sirolimus for chronic allograft nephropathy and calcineurin inhibitor toxicity and the adverse effects of sirolimus after conversion.
    Sayin B; Karakayali H; Colak T; Sevmis S; Pehlivan S; Demirhan B; Haberal M
    Transplant Proc; 2009 Sep; 41(7):2789-93. PubMed ID: 19765436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can a diagnosis of renal allograft rejection be based on histology alone?
    Midtvedt K; Hartmann A; Sund S
    Clin Transplant; 1998 Aug; 12(4):300-2. PubMed ID: 9686323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conversion from calcineurin inhibitor to sirolimus for renal function deterioration in kidney allograft recipients.
    Martínez-Mier G; Méndez-López MT; Estrada-Oros J; Budar-Fernandez LF; Soto-González JI; Méndez-Machado GF; Viñas Dozal JC
    Arch Med Res; 2006 Jul; 37(5):635-8. PubMed ID: 16740435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic renal allograft rejection can be predicted by the surface area under the serum creatinine versus time curve.
    Yilmaz S; Kallio E; Yilmaz A; Häyry P
    Transplant Proc; 1995 Feb; 27(1):927. PubMed ID: 7879233
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical outcome of interval cadaveric renal transplantation in cardiac allograft recipients.
    Kuo PC; Luikart H; Busse-Henry S; Hunt SA; Valantine HA; Stinson EB; Oyer PE; Scandling JD; Alfrey EJ; Dafoe DC
    Clin Transplant; 1995 Apr; 9(2):92-7. PubMed ID: 7599409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of corticosteroid therapy for acute renal allograft rejection.
    Vineyard GC; Fadem SZ; Dmochowski J; Carpenter CB; Wilson RE
    Surg Gynecol Obstet; 1974 Feb; 138(2):225-9. PubMed ID: 4589909
    [No Abstract]   [Full Text] [Related]  

  • 33. Methotrexate is effective in preventing acute and potentially chronic renal allograft rejection.
    Michael B; Francos GC; Burke JF; Gaughan WI
    Transplant Proc; 1994 Oct; 26(5):3046-7. PubMed ID: 7940956
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical trial of Tripterygium Wilfordii Hook F. in human kidney transplantation in China.
    Ji SM; Wang QW; Chen JS; Sha GZ; Liu ZH; Li LS
    Transplant Proc; 2006 Jun; 38(5):1274-9. PubMed ID: 16797280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contrast-induced nephrotoxicity in renal allograft recipients.
    Ahuja TS; Niaz N; Agraharkar M
    Clin Nephrol; 2000 Jul; 54(1):11-4. PubMed ID: 10939751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Magnetic resonance imaging using turbo-FLASH sequences in chronic renal allograft rejection: comparison with echo-Doppler and renal biopsy.
    Mousson C; Krause D; Cercueil JP; Rabec M; Durand C; Justrabo E; Rifle G
    Transplant Proc; 1996 Oct; 28(5):2827-9. PubMed ID: 8908083
    [No Abstract]   [Full Text] [Related]  

  • 37. Is there a time factor in renal allograft rejection?
    Altman DG
    Br Med J; 1979 Mar; 1(6165):748-9. PubMed ID: 373846
    [No Abstract]   [Full Text] [Related]  

  • 38. Stable kidney function in the second decade after kidney transplantation while on cyclosporine-based immunosuppression.
    Kandaswamy R; Humar A; Casingal V; Gillingham KJ; Ibrahim H; Matas AJ
    Transplantation; 2007 Mar; 83(6):722-6. PubMed ID: 17414704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Canine renal allograft rejection and antibody formation following blood transfusions.
    Currier CB; Pierce JC; Hume DM
    Surg Forum; 1973; 24():279-81. PubMed ID: 4618648
    [No Abstract]   [Full Text] [Related]  

  • 40. Membranous nephropathy with chronic renal failure. Partial native renal function recovery after unsuccessful renal transplant.
    Chopra S; Kaufman JS; Hamburger RJ; Flamenbaum W
    Arch Intern Med; 1980 Mar; 140(3):437-8. PubMed ID: 6987969
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.